Dr. Yuichiro D. Nakai

Dr. Lewis Blevins is an endocrinologist specializing in evaluating and managing pituitary and hypothalamus disorders, including acromegaly, prolactinoma and other pituitary tumors, diabetes insipidus, hypopituitarism and growth hormone deficiencies. As medical director of the California Center for Pituitary Disorders at UCSF Medical Center, he guides a team providing comprehensive, state-of-the-art care. He has a special interest in Cushing's syndrome, also known as hypercortisolism, and has edited a book on the subject. In his research, Blevins is interested in evaluating new methods for diagnosing Cushing's syndrome. He also studies the factors that medical professionals can use to predict whether treating pituitary tumors with surgery or other methods will succeed. Blevins earned a medical degree at Quillen College of Medicine at East Tennessee State University and completed a residency in internal medicine at the University of Alabama at Birmingham Hospitals. After completing a fellowship in endocrinology at the Johns Hopkins Hospital, he served on the faculty at Emory University for four years and at Vanderbilt University for nine years. Dr. Blevins is highly rated in 32 conditions, according to our data. His top areas of expertise are Pituitary Tumor, Hypothalamic Tumor, Prolactinoma, and Rathke Cleft Cyst.

Dolores Shoback is an Endocrinologist in San Francisco, California. Dr. Shoback is highly rated in 15 conditions, according to our data. Her top areas of expertise are Hypoparathyroidism, Hypercalcemia, Milk-Alkali Syndrome, Gastric Bypass, and Hormone Replacement Therapy (HRT).

Dr. Umesh Masharani is an endocrinologist who cares for patients with diabetes and thyroid disorders. He also has an endocrine faculty practice. Masharani's research focuses mainly on diabetes, with a particular interest in insulin resistance. He collaborates with colleagues in the family medicine departments to examine the relationships among glucose control, depression and psychosocial stress in people with diabetes. He is part of the islet auto-transplantation group, which has an active program managing patients who require surgical removal of the pancreas for chronic pancreatitis and are candidates for islet auto-transplant, a procedure that allows the patient's body to continue producing insulin. The islet transplant group is also studying donor islet transplants as a treatment for type 1 diabetes. In addition, Masharani is collaborating with Dr. George Brooks, a professor of integrative biology at the University of California, Berkeley, to examine the impact of exercise and aging on mitochondrial function. Masharani earned his bachelor's degree in physiological sciences at the University of Oxford. He earned his medical degree at Middlesex Health in London. He completed his residency in internal medicine at University Hospitals Birmingham NHS Foundation Trust in Birmingham, England. He completed a fellowship in endocrinology at UCSF. Dr. Masharani is highly rated in 29 conditions, according to our data. His top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Anaplastic Thyroid Cancer, Thyroid Cancer, and Islet Cell Transplantation.